Search Results - "Stögmann, E."

Homocysteine – A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia by Futschek, Ines Elisabeth, Schernhammer, E., Haslacher, H., Stögmann, E., Lehrner, J.

“…Subjective Cognitive Decline (SCD) and Mild Cognitive Impairment (MCI) are preclinical stages of Alzheimer's Disease (AD), which is the most common entity of…”
Get full text

Argyrophilic grain disease in individuals younger than 75 years: clinical variability in an under‐recognized limbic tauopathy by Wurm, R., Klotz, S., Rahimi, J., Katzenschlager, R., Lindeck‐Pozza, E., Regelsberger, G., Danics, K., Kapas, I., Bíró, Z. A., Stögmann, E., Gelpi, E., Kovacs, G. G.

“…Background and purpose Argyrophilic grain disease (AGD) is a limbic‐predominant 4R‐tauopathy. AGD is thought to be an age‐related disorder and is frequently…”
Get full text

Identification of odors, faces, cities and naming of objects in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer´s disease: a longitudinal study by Tahmasebi, R, Zehetmayer, S, Pusswald, G, Kovacs, G, Stögmann, E, Lehrner, J

“…ABSTRACTObjective:Recent studies have tried to find a reliable way of predicting the development of Alzheimer´s Disease (AD) among patients with mild cognitive…”
Get more information

Long-term Olfactory Functions in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment by Novotny, D., Stögmann, E., Lehrner, J.

“…Introduction Olfactory function is known to be impaired in patients with Alzheimer’s disease (AD) as well as in subjective cognitive decline (SCD) and mild…”
Get full text

Odor identification testing is inferior compared to neurocognitive testing in predicting conversion to Alzheimer's Disease by Pusswald, G., Ocak, S., Stögmann, E., Lehrner, J.

“…Introduction Alzheimer’s disease (AD) is a neurodegenerative disorder that affects memory, thinking, attention, and emotion or AD. Smelling problems are…”
Get full text

Increased risk of death associated with the use of proton‐pump inhibitors in patients with dementia and controls – a pharmacoepidemiological claims data analysis by Cetin, H., Wurm, R., Reichardt, B., Tomschik, M., Silvaieh, S., Parvizi, T., König, T., Erber, A., Schernhammer, E., Stamm, T., Stögmann, E.

“…Background and purpose The use of proton‐pump inhibitors (PPIs) was reported to be associated with increased mortality risk and has been proposed as a…”
Get full text

Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer’s Disease by Tahmasebi, R., Zehetmayer, S., Stögmann, E., Lehrner, Johann

“…Introduction Hyposmia and metacognitive errors are related to aging, depression, male gender, and cognitive decline. The current study investigated the…”
Get full text

Depressive symptoms and olfactory function in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's disease by Bergmann, C., Stögmann, E., Lehrner, J.

“…•Olfactory function appears to be a potential marker for the discrimination of Alzheimer's disease and depression.•We found a difference in olfactory function…”
Get full text

Heightened Prevalence of Common Hospital-Treated Infections Preceding Dementia Diagnosis with Accelerated Dementia Onset after Influenza by Untersteiner, H., Wurm, R., Reichardt, B., Goeschl, S., Berger-Sieczkowski, E., König, T., Parvizi, T., Silvaieh, S., Stögmann, Elisabeth

“…Background Since the beginning of Alzheimer’s disease research, the hypothesis that infections are to some extent associated with neurodegenerative processes…”
Get full text

Andreas Rett and benign familial neonatal convulsions revisited by ZIMPRICH, F, RONEN, G. M, STÖGMANN, W, BAUMGARTNER, C, STÖGMANN, E, RETT, B, PAPPAS, C, LEPPERT, M, SINGH, N, ANDERSON, V. E

“…In 1964 Andreas Rett published the first account of a family with benign familial neonatal convulsions (BFNC). The authors retraced Rett's family and report…”
Get full text

Hemoglobin A1c Serum Level Predicts 5-year Mortality in Patients with Cognitive Impairment by Dreier, J., Schernhammer, E., Haslacher, H., Stögmann, E., Lehrner, J.

“…Background Subjective cognitive decline (SCD) and mild cognitive impairment (MCI) may occur as preclinical stages of Alzheimer's disease (AD), ultimately…”
Get full text

Hereditary spastic paraplegia caused by compound heterozygous mutations outside the motor domain of the KIF1A gene by Krenn, M., Zulehner, G., Hotzy, C., Rath, J., Stogmann, E., Wagner, M., Haack, T. B., Strom, T. M., Zimprich, A., Zimprich, F.

“…Background and purpose Hereditary spastic paraplegia is a clinically and genetically heterogeneous group of rare, inherited disorders causing an upper motor…”
Get full text

Genotype‐guided diagnostic reassessment after exome sequencing in neuromuscular disorders: experiences with a two‐step approach by Krenn, M., Tomschik, M., Rath, J., Cetin, H., Grisold, A., Zulehner, G., Milenkovic, I., Stogmann, E., Zimprich, A., Strom, T. M., Meitinger, T., Wagner, M., Zimprich, F.

“…Background and purpose Next‐generation sequencing has greatly improved the diagnostic success rates for genetic neuromuscular disorders (NMDs). Nevertheless,…”
Get full text

Autosomal recessive cortical myoclonic tremor and epilepsy: Association with a mutation in the potassium channel associated gene CNTN2 by Stögmann, E.

Get full text

The impact of depressive symptoms on health-related quality of life in patients with subjective cognitive decline, mild cognitive impairment, and Alzheimer's disease by Pusswald, G, Moser, D, Pflüger, M, Gleiss, A, Auff, E, Stögmann, E, Dal-Bianco, P, Lehrner, J

“…Health-related quality of life (HRQOL) is an important issue in the context of dementia care. The purpose of this study was to investigate the association…”
Get more information

Semantic memory and depressive symptoms in patients with subjective cognitive decline, mild cognitive impairment, and Alzheimer's disease by Lehrner, J, Coutinho, G, Mattos, P, Moser, D, Pflüger, M, Gleiss, A, Auff, E, Dal-Bianco, P, Pusswald, G, Stögmann, E

“…Semantic memory may be impaired in clinically recognized states of cognitive impairment. We investigated the relationship between semantic memory and…”
Get more information

Association of an ABCB1 gene haplotype with pharmacoresistance in temporal lobe epilepsy by ZIMPRICH, F, SUNDER-PLASSMANN, R, STOGMANN, E, GLEISS, A, DAL-BIANCO, A, ZIMPRICH, A, PLUMER, S, BAUMGARTNER, C, MANNHALTER, C

“…The multidrug transporter P-glycoprotein is suspected of contributing to pharmacoresistance in temporal lobe epilepsy (TLE). To assess the role of functional…”
Get full text

A splice site variant in the sodium channel gene SCN1A confers risk of febrile seizures by SCHLACHTER, K, GRUBER-SEDLMAYR, U, WICHMANN, H. E, LICHTNER, P, MEITINGER, T, STROM, T. M, ZIMPRICH, A, ZIMPRICH, F, STOGMANN, E, LAUSECKER, M, HOTZY, C, BALZAR, J, SCHUH, E, BAUMGARTNER, C, MUELLER, J. C, ILLIG, T

“…Our aim was to investigate whether the risk of febrile seizures is influenced by a common functional polymorphism in the sodium channel gene SCN1A. This single…”
Get full text

Idiopathic generalized epilepsy phenotypes associated with different EFHC1 mutations by STOGMANN, E, LICHTNER, P, ZIMPRICH, F, ZIMPRICH, A, BAUMGARTNER, C, BONELLI, S, ASSEM-HILGER, E, LEUTMEZER, F, SCHMIED, M, HOTZY, C, STROM, T. M, MEITINGER, T

“…We sequenced 61 patients with various idiopathic generalized epilepsy (IGE) syndromes for mutations in the EFHC1 gene. We detected three novel heterozygous…”
Get full text

A novel mutation in the MFSD8 gene in late infantile neuronal ceroid lipofuscinosis by Stogmann, E., El Tawil, S., Wagenstaller, J., Gaber, A., Edris, S., Abdelhady, A., Assem-Hilger, E., Leutmezer, F., Bonelli, S., Baumgartner, C., Zimprich, F., Strom, T. M., Zimprich, A.

“…Neuronal ceroid lipofuscinoses (NCL) are lysosomal storage disorders and constitute the most common group of progressive neurodegenerative diseases in…”
Get full text